BHCM
TEVA icon

Brevan Howard Capital Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Brevan Howard Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$339K Buy
+10,200
New +$340K ﹤0.01% 1640
2026
Q1 		– Sell
-200,000
Closed -$6.25M – 2487
2025
Q4 		$6.25M Sell
200,000
-109,300
-35% -$2.69M 0.07% 187
2025
Q3 		$6.25M Buy
+309,300
New +$5.43M 0.03% 203

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Brevan Howard Capital Management's TEVA Position: Q2 2026 in Review

Brevan Howard Capital Management opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 10,200 shares worth $339K. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in TEVA as recently as Q4 2025.

Brevan Howard Capital Management first reported a position in TEVA in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.25M in Q4 2025. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Brevan Howard Capital Management held 10,200 shares of Teva Pharmaceutical Industries Limited worth $339K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Brevan Howard Capital Management position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1640 holding.
  • Brevan Howard Capital Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2025 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Teva Pharmaceutical Industries Limited position peaked at $6.25M in Q4 2025.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.